Hola @mrodriguezc.
I hope that @jimchardy returns to answer your question about the treatment he is on. I believe he was referring to either avelumab (BAVENCIO) in combination with axitinib (inlyta)
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-avelumab-plus-axitinib-renal-cell-carcinoma
Or with avelumab with Keytruda (Pembrolizumab)

How are you doing?